05 December 2018

£16 million European collaboration paves the way for new dementia research


 Alzheimer’s Society and other UK funders have united with fifteen countries across Europe, Australia and Canada to support international research collaborations into  dementia and the diseases of the brain that are known to cause it.

The latest Joint Programme – Neurodegenerative Disease (JPND) funding awards represent a €17.5 million (approx. £15.75 million) investment over the next three years.

James Pickett, Head of Research at Alzheimer’s Society, who led the UK funding of the initiative, said: “One person develops dementia every three seconds across the world. Dementia is a global problem, and we need global collaboration to defeat it.

“Alzheimer’s Society is committed to a world without dementia, but we can’t achieve this on our own. Uniting the Department of Health and Social Care (England), Health and Social Research Wales, and Health and Social Care Northern Ireland as well as 15 other countries to fund these eight ambitious new global care research programmes, brings us a step closer to making this a reality.  

“Our funding supports research in the UK, but we know the reach of our work is far wider. Sharing findings internationally and setting up collaborations around the world makes research funding go further, and allows researchers to be a part of cutting-edge dementia research.

“Alzheimer’s Society is committed to spend at least £150 million on dementia research in the next decade and, as the only UK charity funding research into dementia care, cure and prevention, we are delighted to include the Joint Programme – Neurodegenerative Disease as part of our research portfolio.”

For more Insights, click here. 

Below, watch our video 'Flickering Lights' which looks into the lives of those living with dementia and the care they receive by Newcross.